Janssen drops U.S. lawsuit against Samsung Bioepis' Remicade copy

SEOUL (Reuters) - A unit of healthcare conglomerate Johnson& Johnson has dropped a lawsuit it filed to block a copy of its rheumatoid arthritis drug Remicade produced by South Korea's Samsung Bioepis Co Ltd from being sold in the United States.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news